Literature DB >> 25666570

[Bilateral simultaneous central retinal vein occlusion in protein S deficiency].

G Tóth1, G L Sándor2, C Reichel3, G Domján4, Z Z Nagy2, M Ecsedy2.   

Abstract

CASE REPORT: This article reports a case of bilateral simultaneous central retinal vein occlusion (CRVO) and protein S deficiency. The 27-year-old male patient presented with a sudden decrease in vision in both eyes. The patient's medical history documented the death of his father at the age of 33 years due to pulmonary embolism. Thrombophilia screening revealed protein S deficiency.
OBJECTIVES: We report this case to emphasize that in any case of young onset retinal vein occlusion, protein S deficiency should be suspected.
CONCLUSIONS: Thrombophilia assays and taking a thorough medical history should be performed.

Entities:  

Keywords:  Medical history taking; Retinal vein occlusion; Thrombophilia; Thrombophilia screening; Visual deterioration

Mesh:

Year:  2015        PMID: 25666570     DOI: 10.1007/s00347-015-3234-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  10 in total

1.  [Thrombophilic and systemic risk factors in patients with retinal vein occlusion].

Authors:  C Kuhli-Hattenbach; W Miesbach; I Scharrer; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

Review 2.  Diabetes mellitus and thrombosis.

Authors:  Natale Vazzana; Paola Ranalli; Chiara Cuccurullo; Giovanni Davì
Journal:  Thromb Res       Date:  2011-12-24       Impact factor: 3.944

3.  Hematologic abnormalities associated with various types of retinal vein occlusion.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Patricia Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-02-09       Impact factor: 3.117

Review 4.  Protein S abnormalities: a diagnostic nightmare.

Authors:  Richard A Marlar; Jana N Gausman
Journal:  Am J Hematol       Date:  2011-05       Impact factor: 10.047

5.  Coagulation disorders and the risk of retinal vein occlusion.

Authors:  C Kuhli-Hattenbach; I Scharrer; M Lüchtenberg; L-O Hattenbach
Journal:  Thromb Haemost       Date:  2009-11-13       Impact factor: 5.249

6.  Baseline and early natural history report. The Central Vein Occlusion Study.

Authors: 
Journal:  Arch Ophthalmol       Date:  1993-08

7.  [Selective thrombophilia screening of young patients with retinal vein occlusion].

Authors:  C Kuhli-Hattenbach; I Scharrer; M Lüchtenberg; L O Hattenbach
Journal:  Klin Monbl Augenheilkd       Date:  2009-04-27       Impact factor: 0.700

8.  Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.

Authors:  Thomas Bombeli; Adila Basic; Joerg Fehr
Journal:  Am J Hematol       Date:  2002-06       Impact factor: 10.047

9.  Anticoagulant therapy after retinal vein occlusion in patients with protein S deficiency (Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion. Vol. 42[4]).

Authors:  Matus Rehak; Vera Krcova; Ludek Slavik; Marc Müller; Jiri Rehak
Journal:  Can J Ophthalmol       Date:  2007-12       Impact factor: 1.882

Review 10.  Hypercoagulable states and central retinal vein occlusion.

Authors:  J Michael Lahey; John J Kearney; Murat Tunc
Journal:  Curr Opin Pulm Med       Date:  2003-09       Impact factor: 3.155

  10 in total
  3 in total

1.  [Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].

Authors:  C Kuhli-Hattenbach; P Hellstern; W Miesbach; T Kohnen; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2017-12       Impact factor: 1.059

2.  Clinicopathological Review of 547 Bulbar Enucleations in Hungary (2006-2017).

Authors:  Gábor Tóth; Nóra Szentmáry; Gábor László Sándor; Béla Csákány; Erika Maka; Jeannette Tóth; Zsuzsanna Antus; Milán Tamás Pluzsik; Achim Langenbucher; Zoltán Zsolt Nagy; Olga Lukáts
Journal:  J Ophthalmol       Date:  2019-02-14       Impact factor: 1.909

3.  Bilateral Central Retinal Vein Occlusion as a First Presentation of Multiple Myeloma: A Case Report.

Authors:  Michael Andrew Tandlich; Kelly Williamson
Journal:  Clin Pract Cases Emerg Med       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.